These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 2173469

  • 1. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
    Spandidos DA, Zakinthinos S, Petraki C, Sotsiou F, Yiagnisis M, Dimopoulos AM, Roussos C, Field JK.
    Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
    [Abstract] [Full Text] [Related]

  • 2. Immunocytochemical study of RAS oncoprotein in cytologic specimens of primary lung tumours.
    Koutselini H, Kappatou G, Yiagnisis M, Field JK, Spandidos DA.
    Anticancer Res; 1990; 10(3):597-603. PubMed ID: 2164347
    [Abstract] [Full Text] [Related]

  • 3. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
    Pavelic K, Antonic M, Pavelic L, Pavelic J, Pavelic Z, Spaventi S.
    Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
    Miyamoto H, Harada M, Isobe H, Akita HD, Haneda H, Yamaguchi E, Kuzumaki N, Kawakami Y.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6346-50. PubMed ID: 1657384
    [Abstract] [Full Text] [Related]

  • 5. Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: comparison with immunohistochemical results.
    De Santis L, Mangili F, Sassi I, Di Rocco M, Rossi C, Cantaboni A.
    Anal Cell Pathol; 1995 Apr 01; 8(3):247-57. PubMed ID: 7547497
    [Abstract] [Full Text] [Related]

  • 6. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
    Tiniakos D, Spandidos DA, Yiagnisis M, Tiniakos G.
    Hepatogastroenterology; 1993 Feb 01; 40(1):37-40. PubMed ID: 8462926
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma.
    Spandidos DA, Kaloterakis A, Yiagnisis M, Varatsos A, Field JK.
    Anticancer Res; 1990 Feb 01; 10(6):1619-25. PubMed ID: 1980998
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
    Mizukami Y, Nonomura A, Noguchi M, Taniya T, Koyasaki N, Saito Y, Hashimoto T, Matsubara F, Yanaihara N.
    Anticancer Res; 1991 Feb 01; 11(4):1485-94. PubMed ID: 1660689
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical detection of ras p21 and c-myc p62 in colonic adenomas and carcinomas.
    Agnantis NJ, Apostolikas N, Sficas C, Zolota V, Spandidos DA.
    Hepatogastroenterology; 1991 Jun 01; 38(3):239-42. PubMed ID: 1937363
    [Abstract] [Full Text] [Related]

  • 12. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
    Schwartz B, Benharroch D, Prinsloo I, Cagnano E, Lamprecht SA.
    Anticancer Res; 1995 Jun 01; 15(1):211-8. PubMed ID: 7537485
    [Abstract] [Full Text] [Related]

  • 13. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
    Spandidos DA, Yiagnisis M, Papadimitriou K, Field JK.
    Anticancer Res; 1989 Jun 01; 9(5):1385-93. PubMed ID: 2574023
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
    Karayiannis M, Yiagnisis M, Papadimitriou K, Field JK, Spandidos DA.
    Anticancer Res; 1990 Jun 01; 10(5A):1127-33. PubMed ID: 2241094
    [Abstract] [Full Text] [Related]

  • 15. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
    Volm M, Efferth T, Mattern J.
    Anticancer Res; 1992 Jun 01; 12(1):11-20. PubMed ID: 1348920
    [Abstract] [Full Text] [Related]

  • 16. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J, Horáková I, Novotná H, Opáalka P, Roubková H.
    Clin Cancer Res; 1995 Mar 01; 1(3):359-65. PubMed ID: 9815992
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin.
    Pavlidis N, Briassoulis E, Bai M, Fountzilas G, Agnantis N.
    Anticancer Res; 1995 Mar 01; 15(6B):2563-7. PubMed ID: 8669824
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products].
    Roa I, Araya JC, Shiraishi T, Yatani R, Wistuba I, Villaseca M, de Aretxabala X.
    Rev Med Chil; 1994 Jul 01; 122(7):754-9. PubMed ID: 7732224
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.